Subject:
|
EBP 3: Effective Primary Care and Public Health N4i 1: Pathogenesis and modulation of inflammation N4i 2: Invasive mycoses and compromised host N4i 3: Poverty-related infectious diseases NCEBP 13: Infectious diseases and international health NCMLS 1: Infection and autoimmunity UMCN 3.2: Cognitive neurosciences UMCN 4.1: Microbial pathogenesis and host defense |
Organization:
|
Internal Medicine Clinical Pharmacy Medical Microbiology |
Abstract:
|
A systemic review is presented of all studies that have evaluated the inhibitory quotient (IQ). The IQ is defined as the ratio between (trough) drug concentration and level of drug resistance of the HIV isolate. From the studies presented, it can be concluded that for protease inhibitors (PIs) and efavirenz, the phenotypic IQ is associated with virological response. The genotypic IQ (GIQ) for PIs was also demonstrated to be associated with virological response. An intrinsic limitation of the GIQ is that it is only applicable for PIs, of which resistance is based on the cumulative effect of mutations. As the IQ can be modified by adjustment of the drug dosage, it may be of clinical value. Its application in patient care should therefore be further investigated.
|